IQVIA Selects Veeva Clinical Operations Applications
Business Wire•13/10/2026•07:03 ET
0
Key Highlights
- ➤IQVIA selects Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standards
- ➤Expanded partnership extends previously announced EDC collaboration across IQVIA clinical development studies
- ➤IQVIA and Veeva aim to improve trial speed, site efficiency, and patient access to treatments
Expert Statements
Richard Staub, President of Research and Development Solutions at IQVIA
“By bringing our companies’ strengths together, we’re giving clinical teams a more connected way to work, built on frictionless integration of our respective technologies.”
Richard Staub, President of Research and Development Solutions at IQVIA
“Just as importantly, customers retain the flexibility to choose the EDC, RTSM, and eCOA technologies and solutions that best meet their needs, including IQVIA’s innovative capabilities.”
Peter Gassner, Founder and CEO of Veeva Systems
“This is an exciting expansion of the partnership IQVIA and Veeva announced last year and the work we have done together since.”
Peter Gassner, Founder and CEO of Veeva Systems
“We are committed to supporting seamless product and services integration for the benefit of our customers and improving access to innovations for patients.”
IQVIA (NYSE:IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies. This extends the previously announced EDC partnership.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261013187834/en/
Get started
Create a free account to read the full story.